• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC INTRODUCER SHEATH (DRYSEAL FLEX VER 4.0); INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC INTRODUCER SHEATH (DRYSEAL FLEX VER 4.0); INTRODUCER, CATHETER Back to Search Results
Catalog Number DSF1833
Device Problem Material Separation (1562)
Patient Problem Device Embedded In Tissue or Plaque (3165)
Event Date 06/13/2019
Event Type  Injury  
Manufacturer Narrative
Patient medications: zyloprim, aspirin, lipitor, colchicine, florinef, lortab, meclizine, proamatine the review of the manufacturing paperwork verified that the lot met all pre-release specifications.As the device was discarded, and no evaluation of the device could be performed, cause was unable to be established.
 
Event Description
On (b)(6) 2019 the patient underwent endovascular repair of an abdominal aortic aneurysm using a gore® dryseal flex sheath as an accessory in the procedure.It was reported that the patient had a previously implanted cook medical iliac graft (type unknown) located in the right common iliac artery.The patient's right internal iliac artery was previously coiled and covered.The gore® dryseal flex sheath was advanced on the patient's left side.Tortuosity of the patient's access vessel was noted.No resistance upon sheath advancement was noted.An rlt281416 gore® excluder® aaa endoprosthesis trunk-ipsilateral leg component was advanced.The trunk of the device was successfully deployed.Resistance was noted upon attempted removal of the gore® dryseal flex sheath.Reportedly it was suspected that the leading end of the sheath had become lodged within the struts of the previously implanted cook medical graft.Removal of the sheath was attempted again and it was reported that the gore® dryseal flex sheath split into two pieces.Reportedly no excessive force was used during attempted removal.The trailing end of the sheath was successfully removed.The leading end of the sheath remains in the patient's right common iliac artery.Reportedly the physician performed aorto-uni-iliac stent grafting and a femoral to femoral bypass with ligation of the patient's iliac artery.There were no further reported issues.The patient tolerated the procedure.
 
Event Description
See h10/11 for updated/corrected event information.
 
Manufacturer Narrative
B.5.Event description updated/corrected.It was initially reported that the gore® dryseal flex sheath was advanced on the patient's left side.Supplemental information was received to clarify that the gore® dryseal flex sheath was advanced on the patient's right side, thereby becoming lodged within the proximal struts of the previously implanted cook medical graft located in the patient's right common iliac artery.All other reported information was confirmed to be accurate, and therefore remains unchanged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC INTRODUCER SHEATH (DRYSEAL FLEX VER 4.0)
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8770024
MDR Text Key150396607
Report Number3007284313-2019-00195
Device Sequence Number1
Product Code DYB
UDI-Device Identifier00733132630042
UDI-Public00733132630042
Combination Product (y/n)N
PMA/PMN Number
K160254
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 07/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/08/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/04/2021
Device Catalogue NumberDSF1833
Device Lot Number18713585
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
SEE H10/11 FOR LIST OF MEDICATIONS.
Patient Outcome(s) Other; Required Intervention;
Patient Age76 YR
Patient Weight121
-
-